Zealand Pharma A/S (ZEAL.CO)

DKK 446.1

(-1.26%)

Inventory Summary of Zealand Pharma A/S

  • Zealand Pharma A/S's latest annual inventory in 2023 was 7.93 Million DKK , up 517.03% from previous year.
  • Zealand Pharma A/S's latest quarterly inventory in 2024 Q2 was 803 Thousand DKK , down -72.47% from previous quarter.
  • Zealand Pharma A/S reported annual inventory of 1.28 Million DKK in 2022, down -98.91% from previous year.
  • Zealand Pharma A/S reported annual inventory of 118.43 Million DKK in 2021, up 159.16% from previous year.
  • Zealand Pharma A/S reported quarterly inventory of 2.91 Million DKK for 2024 Q1, down -63.24% from previous quarter.
  • Zealand Pharma A/S reported quarterly inventory of 7.93 Million DKK for 2023 FY, up 517.03% from previous quarter.

Annual Inventory Chart of Zealand Pharma A/S (2023 - 2007)

Historical Annual Inventory of Zealand Pharma A/S (2023 - 2007)

Year Inventory Inventory Growth
2023 7.93 Million DKK 517.03%
2022 1.28 Million DKK -98.91%
2021 118.43 Million DKK 159.16%
2020 45.7 Million DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK 0.0%
2015 - DKK -100.0%
2014 1.00 DKK 100.0%
2013 -6.43 Million DKK 0.0%
2012 - DKK 0.0%
2011 - DKK 0.0%
2010 - DKK 0.0%
2009 - DKK 0.0%
2008 - DKK 0.0%
2007 - DKK 0.0%

Peer Inventory Comparison of Zealand Pharma A/S

Name Inventory Inventory Difference
ALK-Abelló A/S 1.42 Billion DKK 99.442%
Bavarian Nordic A/S 1.64 Billion DKK 99.517%
Genmab A/S 57 Million DKK 86.079%
Gubra A/S -403.98 Million DKK 101.964%
Novo Nordisk A/S 31.81 Billion DKK 99.975%
Orphazyme A/S -1099.00 DKK 722120.018%
Pharma Equity Group A/S 1000.00 DKK -793400.0%